HomeOCX • NASDAQ
add
OncoCyte Corp
Previous close
$2.56
Day range
$2.49 - $2.55
Year range
$2.08 - $6.20
Market cap
21.06M USD
Avg Volume
104.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 314.00K | — |
Operating expense | 5.55M | — |
Net income | -15.99M | — |
Net profit margin | -5.09K | — |
Earnings per share | — | — |
EBITDA | -5.22M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.43M | -53.82% |
Total assets | 74.89M | -25.18% |
Total liabilities | 49.30M | -18.51% |
Total equity | 25.59M | — |
Shares outstanding | 8.26M | — |
Price to book | 1.03 | — |
Return on assets | -18.05% | — |
Return on capital | -38.15% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -15.99M | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2009
Headquarters
Website
Employees
43
